Aug 14, 2019 Avenue Therapeutics Reports Second Quarter 2019 Financial Results and Recent Corporate Highlights
Aug 01, 2019 Avenue Therapeutics Announces Appointment of Ms. E. Garrett Ingram to Board of Directors
Jun 03, 2019 Avenue Therapeutics Announces Positive Topline Data from Second Pivotal Phase 3 Study of Intravenous Tramadol in the Management of Postoperative Pain
May 13, 2019 Avenue Therapeutics Reports First Quarter 2019 Financial Results and Recent Corporate Highlights
Mar 12, 2019 Avenue Therapeutics Reports Full Year 2018 Financial Results and Recent Corporate Highlights
Feb 11, 2019 Avenue Therapeutics Announces First Stage Closing of its Acquisition Agreement with InvaGen (a Cipla subsidiary)
Dec 19, 2018 Avenue Therapeutics Announces Dosing of First Patient in Second Pivotal Phase 3 Clinical Trial of Intravenous Tramadol for the Management of Postoperative Pain
Nov 14, 2018 Avenue Therapeutics Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights
Nov 13, 2018 InvaGen (a Cipla subsidiary) Announces Acquisition Agreement with Avenue Therapeutics for Specialty Hospital Business in the U.S.
